Interleukin-6 Receptor Antagonist [EPC]

60922 reported adverse events

Drugs of this class: SARILUMAB TOCILIZUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-6 Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 21887
1 RHEUMATOID ARTHRITIS 11925
2 PAIN 8534
3 ARTHRALGIA 7267
4 JOINT SWELLING 6327
5 OFF LABEL USE 5867
6 DRUG INTOLERANCE 5767
7 FATIGUE 5253
8 CONTRAINDICATED PRODUCT ADMINISTERED 4811
9 RASH 4760
See all common reactions for Interleukin-6 Receptor Antagonist [EPC]

Drugs of the Interleukin-6 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 268 0.9338
1 DISABILITY ASSESSMENT SCALE SCORE INCREASED 153 0.8895
2 RHEUMATOID FACTOR NEGATIVE 112 0.7778
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 667 0.7649
4 RED BLOOD CELL SEDIMENTATION RATE 77 0.7130
5 RHEUMATOID FACTOR POSITIVE 1007 0.6718
6 JOINT LAXITY 116 0.5859
7 PEMPHIGUS 1633 0.5853
8 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 909 0.5827
9 SWOLLEN JOINT COUNT INCREASED 65 0.5752
See all enriched reactions for Interleukin-6 Receptor Antagonist [EPC]